|
| 36932902 | Missense variant in RBM10 associated with mild and non-lethal form of TARP syndrome. | Clin Genet | 2023 |
| 37506692 | Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon. | Am J Hum Genet | 2023 |
| 37347242 | ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 34906498 | Artificial intelligence (AI)-assisted exome reanalysis greatly aids in the identification of new positive cases and reduces analysis time in a clinical diagnostic laboratory. | Genet Med | 2022 |
| 35802134 | ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2022 |
| 35429647 | An Educational Assessment of Evidence Used for Variant Classification: A Report of the Association for Molecular Pathology. | J Mol Diagn | 2022 |
| 34012068 | ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34345026 | Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34012069 | Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 32404922 | CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2020 |
| 30670880 | Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 30287922 | Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 29323668 | Professional responsibilities regarding the provision, publication, and dissemination of patient phenotypes in the context of clinical genetic and genomic testing: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2018 |
| 30133189 | Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience. | Mol Genet Genomic Med | 2018 |
| 30297698 | Venous thromboembolism laboratory testing (factor V Leiden and factor II c.*97G>A), 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2018 |
| 30455898 | A case for expanding carrier testing to include actionable X-linked disorders. | Clin Case Rep | 2018 |
| 29754767 | Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory. | Am J Hum Genet | 2018 |
| 29543230 | Response to Biesecker and Harrison. | Genet Med | 2018 |
| 29733724 | Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision Making. | Health Aff (Millwood) | 2018 |
| 27940182 | Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing. | Contemp Clin Trials | 2017 |
| 28079899 | Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing. | Genet Med | 2017 |
| 27854360 | Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. | Genet Med | 2017 |
| 27811861 | A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories. | Genet Med | 2017 |
| 26792268 | Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing. | Am J Med Genet A | 2016 |
| 27392081 | Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. | Am J Hum Genet | 2016 |
| 27253733 | Results from an external proficiency testing program: 11 years of molecular genetics testing for myotonic dystrophy type 1. | Genet Med | 2016 |
| 27181684 | Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. | Am J Hum Genet | 2016 |
| 26889673 | Generating a taxonomy for genetic conditions relevant to reproductive planning. | Am J Med Genet A | 2016 |
| 26820065 | Evidence for an association between infant mortality and homozygosity for the arctic variant of carnitine palmitoyltransferase 1A. | Genet Med | 2016 |
| 25077647 | Molecular genetic testing for cystic fibrosis: laboratory performance on the College of American Pathologists external proficiency surveys. | Genet Med | 2015 |
| 25637381 | Actionable exomic incidental findings in 6503 participants: challenges of variant classification. | Genome Res | 2015 |
| 25741868 | Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. | Genet Med | 2015 |
| 23703682 | Three-year experience of a CAP/ACMG methods-based external proficiency testing program for laboratories offering DNA sequencing for rare inherited disorders. | Genet Med | 2014 |
| 24788807 | Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample. | PLoS One | 2014 |
| 24650895 | Methods-based proficiency testing in molecular genetic pathology. | J Mol Diagn | 2014 |
| 22955111 | Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update. | Genet Med | 2013 |
| 23808472 | Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics. | Arch Pathol Lab Med | 2013 |
| 23348768 | ACMG Policy Statement. Risk categorization for oversight of laboratory-developed tests for inherited conditions. | Genet Med | 2013 |
| 22237433 | Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey. | Genet Med | 2012 |
| 22534075 | Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories. | BMC Res Notes | 2012 |
| 20843525 | Prevalence and distribution of the c.1436Câ¿¿T sequence variant of carnitine palmitoyltransferase 1A among Alaska Native infants. | J Pediatr | 2011 |
| 21354051 | Quality assurance for Duchenne and Becker muscular dystrophy genetic testing: development of a genomic DNA reference material panel. | J Mol Diagn | 2011 |
| 21480184 | Quality assurance and quality improvement in U.S. clinical molecular genetic laboratories. | Curr Protoc Hum Genet | 2011 |
| 20960468 | How to catch all those mutations--the report of the third Human Variome Project Meeting, UNESCO Paris, May 2010. | Hum Mutat | 2010 |
| 19306394 | Planning the human variome project: the Spain report. | Hum Mutat | 2009 |
| 19367192 | Validation of Fanconi anemia complementation Group A assignment using molecular analysis. | Genet Med | 2009 |
| 18165276 | Consensus characterization of 16 FMR1 reference materials: a consortium study. | J Mol Diagn | 2008 |
| 18988827 | GENETICS. The Human Variome Project. | Science | 2008 |
| 18496029 | New quality assurance standards for rare disease testing. | Genet Med | 2008 |
| 18414213 | ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. | Genet Med | 2008 |